Home The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects
Article
Licensed
Unlicensed Requires Authentication

The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects

  • Mojca Stegnar , Anja Kneževič and Mojca Božič-Mijovski
Published/Copyright: July 12, 2010

Abstract

Background: Although light transmittance aggregometry is considered the gold standard for platelet function testing, it is poorly standardized. The effect of several pre-analytical variables on this assay was investigated.

Methods: Light transmittance aggregometry was performed with an automated coagulation analyzer using arachidonic acid (1.6 mmol/L), adenosine-5-diphosphate (ADP) (11 μmol/L) and collagen (11 mg/L, all final concentrations). The results were reported as maximum aggregation (in %) in 10 min. Twenty apparently healthy subjects were tested three times on two consecutive days: on day 1, fasting samples were collected in the morning and mid-day; on day 2, samples were collected in the morning after a light breakfast. Light transmittance aggregometry was performed immediately after preparation of platelet-rich-plasma (PRP), after stabilization (30 min) of non-adjusted and platelet count (225–275×109/L) adjusted PRP, and at 2 and 4 h after blood collection.

Results: Maximum aggregation was higher in the non-adjusted compared to the adjusted PRP with all three agonists used (all p<0.05). Arachidonic acid and ADP, but not collagen, induced maximal aggregation was significantly decreased after 4 h (arachidonic acid from 84%, 73%–90% to 71%, 28%–85%, p<0.001; ADP from 79%, 62%–87% to 66%, 50%–79%, p<0.001, medians with inter-quartile ranges). Short-term stabilization of PRP, consumption of breakfast and sampling at mid-day had no significant effect on maximal aggregation.

Conclusions: Blood collection and plasma preparation can be simplified by omitting short-term stabilization of PRP and adjustment for platelet count. The subjects can be tested from morning to mid-day, and a light breakfast is acceptable. However, the analyses should not be postponed for more than 2 h if arachidonic acid or ADP are used as agonists.

Clin Chem Lab Med 2010;48:1463–5.


Corresponding author: Prof. Mojca Stegnar, PhD, Department of Vascular Diseases, University Medical Centre Ljubljana, SI-1525 Ljubljana, Slovenia Phone: +386 1 522 8032, Fax: +386 1 522 8070,

Received: 2009-11-9
Accepted: 2010-4-14
Published Online: 2010-07-12
Published in Print: 2010-10-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Darwinian evolution or regression? The fate of laboratory professionals
  3. Review
  4. Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis
  5. Minireview
  6. Laboratory diagnostics in acute poisoning: critical overview
  7. Opinion Papers
  8. On the origins of physicians: Darwinian or Lamarckian evolution?
  9. Observed, unknown distributions of clinical chemical quantities should be considered to be log-normal: a proposal
  10. Guidelines and Recommendations
  11. Development and description of GETT: a Genetic testing Evidence Tracking Tool
  12. Genetics and Molecular Diagnostics
  13. DNA sequencing errors in molecular diagnostics of filamin myopathy
  14. High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene
  15. General Clinical Chemistry and Laboratory Medicine
  16. Detection of serum free light chains: the problem with antigen excess
  17. Hepcidin concentrations and iron homeostasis in preeclampsia
  18. Automated assay for non-transferrin-bound iron in serum samples
  19. A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose
  20. Evaluation of a multiplex assay for adipokine concentrations in obese children
  21. The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
  22. Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265
  23. The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects
  24. Cancer Diagnostics
  25. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers
  26. VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma
  27. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer
  28. Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients
  29. Spurious increase in serum chromogranin A: the role of heterophilic antibodies
  30. Infectious Diseases
  31. Identification and evaluation of a new nucleic acid amplification test target for specific detection of Mycobacterium tuberculosis
  32. Application of an oligonucleotide microarray-based nano-amplification technique for the detection of fungal pathogens
  33. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma
  34. Evaluation of two sirolimus assays using the ARCHITECT-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method
  35. Widespread use of point-of-care testing is irreconcilable with the present-day quest for safety
  36. Congress Abstracts
  37. 3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry Salzburg, Austria, 27-30 October 2010
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.285/html
Scroll to top button